Company / FCF Margin
Corbus Pharmaceuticals Holdings, Inc. FCF Margin History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-5471.0%
FY2022
5-year range
-5471.0% / -134.1%
FY2018-FY2022
Trend
-115.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -134.1% to -5471.0% over the past 2 years.
Based on SEC 10-K filings.
-5471.0% in FY2022 with a 5-year CAGR of -4740.1%.
Declined from -134.1% to -5471.0% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -4799.8pp
- 5-Year Change
- -4740.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, fcf margin decreased 115.0% year-over-year.
- Peak fcf margin was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -5471.0% | -115.0% |
| FY2021 | -2544.2% | -1797.4% |
| FY2020 | -134.1% | +80.0% |
| FY2019 | -671.2% | +42.5% |
| FY2018 | -1168.1% | -59.8% |
| FY2017 | -730.9% | +0.0% |
| FY2016 | -730.9% | -95.4% |
| FY2015 | -374.1% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026